25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ARVN (Arvinas) Stock Analysis
Buy, Hold or Sell?

Let's analyze Arvinas together

I guess you are interested in Arvinas Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Arvinas’s Financial Insights
  • 📈 Technical Analysis (TA) – Arvinas’s Price Targets

I'm going to help you getting a better view of Arvinas Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Arvinas Inc

I send you an email if I find something interesting about Arvinas Inc.

1. Quick Overview

1.1. Quick analysis of Arvinas (30 sec.)










1.2. What can you expect buying and holding a share of Arvinas? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$9.04
Expected worth in 1 year
$9.73
How sure are you?
29.4%

+ What do you gain per year?

Total Gains per Share
$0.69
Return On Investment
9.0%

For what price can you sell your share?

Current Price per Share
$7.63
Expected price per share
$5.935 - $13.57
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Arvinas (5 min.)




Live pricePrice per Share (EOD)
$7.63
Intrinsic Value Per Share
$-50.89 - $-59.47
Total Value Per Share
$-41.85 - $-50.42

2.2. Growth of Arvinas (5 min.)




Is Arvinas growing?

Current yearPrevious yearGrowGrow %
How rich?$660.1m$547.6m$54.3m9.0%

How much money is Arvinas making?

Current yearPrevious yearGrowGrow %
Making money-$11.6m-$88.7m$77m661.4%
Net Profit Margin-31.6%-55.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Arvinas (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#100 / 884

Most Revenue
#83 / 884

Most Profit
#559 / 884

Most Efficient
#463 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Arvinas?

Welcome investor! Arvinas's management wants to use your money to grow the business. In return you get a share of Arvinas.

First you should know what it really means to hold a share of Arvinas. And how you can make/lose money.

Speculation

The Price per Share of Arvinas is $7.63. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arvinas.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arvinas, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $9.04. Based on the TTM, the Book Value Change Per Share is $0.17 per quarter. Based on the YOY, the Book Value Change Per Share is $0.34 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arvinas.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.1414.9%-0.16-2.1%-1.22-15.9%-0.80-10.5%-0.72-9.5%-0.58-7.5%
Usd Book Value Change Per Share1.3517.7%0.172.3%0.344.4%-0.07-0.9%0.314.0%0.273.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.3517.7%0.172.3%0.344.4%-0.07-0.9%0.314.0%0.273.5%
Usd Price Per Share7.02-19.36-31.73-29.37-43.46-30.55-
Price to Earnings Ratio1.55--7.29--7.03--7.84--15.34--13.46-
Price-to-Total Gains Ratio5.21--95.88--76.83--74.70--70.04--69.80-
Price to Book Ratio0.78-2.39-4.13-3.69-5.70-6.35-
Price-to-Total Gains Ratio5.21--95.88--76.83--74.70--70.04--69.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.63
Number of shares131
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.170.31
Usd Total Gains Per Share0.170.31
Gains per Quarter (131 shares)22.6140.24
Gains per Year (131 shares)90.45160.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1090800161151
201811700322312
302712600483473
403623500644634
504524400805795
605435300966956
70633620011271117
80724710012881278
90814800014491439
100905890016091600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%2.032.00.05.9%2.032.00.05.9%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%10.021.03.029.4%10.021.03.029.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%10.021.03.029.4%10.021.03.029.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Arvinas Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.3480.173+681%0.338+299%-0.072+105%0.307+339%0.266+407%
Book Value Per Share--9.0448.248+10%7.503+21%7.954+14%7.900+14%5.123+77%
Current Ratio--4.5784.252+8%4.155+10%4.417+4%6.671-31%6.090-25%
Debt To Asset Ratio--0.3410.464-27%0.533-36%0.514-34%0.423-20%0.427-20%
Debt To Equity Ratio--0.5170.896-42%1.154-55%1.083-52%0.851-39%8.742-94%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--1125699628.0001967688504.000-43%2818177165.000-60%2673209910.833-58%3701063477.500-70%3232316185.667-65%
Eps--1.136-0.160+114%-1.215+207%-0.802+171%-0.722+164%-0.575+151%
Ev To Ebitda Ratio--3.871-6.900+278%-7.626+297%-8.834+328%-17.440+551%-19.931+615%
Ev To Sales Ratio--1.4915.856-75%9.463-84%13.387-89%96.530-98%95.744-98%
Free Cash Flow Per Share---1.223-0.866-29%-1.2190%-1.053-14%-0.346-72%-0.243-80%
Free Cash Flow To Equity Per Share---1.225-0.845-31%0.064-2002%-0.614-50%0.455-369%0.352-448%
Gross Profit Margin--1.0001.012-1%1.009-1%1.007-1%1.0040%1.0020%
Intrinsic Value_10Y_max---59.467----------
Intrinsic Value_10Y_min---50.891----------
Intrinsic Value_1Y_max---4.471----------
Intrinsic Value_1Y_min---4.390----------
Intrinsic Value_3Y_max---14.567----------
Intrinsic Value_3Y_min---13.884----------
Intrinsic Value_5Y_max---26.030----------
Intrinsic Value_5Y_min---24.063----------
Market Cap556924382.000+8%512399628.0001413113504.000-64%2315652165.000-78%2143818244.167-76%3172388722.500-84%2229801397.765-77%
Net Profit Margin--0.439-0.316+172%-0.556+227%-1.041+337%-3.291+849%-3.223+834%
Operating Margin----0.5550%-0.7400%-1.1620%-3.3840%-3.2880%
Operating Ratio--0.6221.464-58%1.760-65%2.185-72%4.456-86%5.313-88%
Pb Ratio0.844+8%0.7762.393-68%4.134-81%3.687-79%5.697-86%6.346-88%
Pe Ratio1.680+8%1.545-7.287+572%-7.027+555%-7.842+608%-15.338+1093%-13.458+971%
Price Per Share7.630+8%7.02019.360-64%31.725-78%29.371-76%43.463-84%30.549-77%
Price To Free Cash Flow Ratio-1.559-9%-1.4340.181-895%-6.497+353%-5.059+253%-13.662+852%4.315-133%
Price To Total Gains Ratio5.660+8%5.207-95.877+1941%-76.825+1575%-74.696+1534%-70.039+1445%-69.800+1440%
Quick Ratio--8.5797.950+8%7.634+12%8.213+4%11.452-25%10.521-18%
Return On Assets--0.083-0.007+109%-0.074+190%-0.046+156%-0.053+164%-0.081+198%
Return On Equity--0.126-0.024+119%-0.158+226%-0.103+182%-0.097+178%-0.703+660%
Total Gains Per Share--1.3480.173+681%0.338+299%-0.072+105%0.307+339%0.266+407%
Usd Book Value--660100000.000602000000.000+10%547625000.000+21%580541666.667+14%576632062.700+14%373956193.471+77%
Usd Book Value Change Per Share--1.3480.173+681%0.338+299%-0.072+105%0.307+339%0.266+407%
Usd Book Value Per Share--9.0448.248+10%7.503+21%7.954+14%7.900+14%5.123+77%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--1125699628.0001967688504.000-43%2818177165.000-60%2673209910.833-58%3701063477.500-70%3232316185.667-65%
Usd Eps--1.136-0.160+114%-1.215+207%-0.802+171%-0.722+164%-0.575+151%
Usd Free Cash Flow---89300000.000-63200000.000-29%-89000000.0000%-76850000.000-14%-25229614.100-72%-17773018.441-80%
Usd Free Cash Flow Per Share---1.223-0.866-29%-1.2190%-1.053-14%-0.346-72%-0.243-80%
Usd Free Cash Flow To Equity Per Share---1.225-0.845-31%0.064-2002%-0.614-50%0.455-369%0.352-448%
Usd Market Cap556924382.000+8%512399628.0001413113504.000-64%2315652165.000-78%2143818244.167-76%3172388722.500-84%2229801397.765-77%
Usd Price Per Share7.630+8%7.02019.360-64%31.725-78%29.371-76%43.463-84%30.549-77%
Usd Profit--82900000.000-11650000.000+114%-88700000.000+207%-58191666.667+170%-52514874.900+163%-35947329.735+143%
Usd Revenue--188800000.000106725000.000+77%17825000.000+959%52525000.000+259%35836535.850+427%23368194.676+708%
Usd Total Gains Per Share--1.3480.173+681%0.338+299%-0.072+105%0.307+339%0.266+407%
 EOD+5 -3MRQTTM+24 -13YOY+23 -143Y+23 -145Y+21 -1610Y+22 -15

3.3 Fundamental Score

Let's check the fundamental score of Arvinas Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151.680
Price to Book Ratio (EOD)Between0-10.844
Net Profit Margin (MRQ)Greater than00.439
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.579
Current Ratio (MRQ)Greater than14.578
Debt to Asset Ratio (MRQ)Less than10.341
Debt to Equity Ratio (MRQ)Less than10.517
Return on Equity (MRQ)Greater than0.150.126
Return on Assets (MRQ)Greater than0.050.083
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of Arvinas Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.518
Ma 20Greater thanMa 507.486
Ma 50Greater thanMa 1007.450
Ma 100Greater thanMa 2009.819
OpenGreater thanClose7.400
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Arvinas Inc

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.

Fundamental data was last updated by Penke on 2025-06-18 23:46:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Arvinas earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • A Net Profit Margin of 43.9% means that $0.44 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arvinas Inc:

  • The MRQ is 43.9%. The company is making a huge profit. +2
  • The TTM is -31.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ43.9%TTM-31.6%+75.5%
TTM-31.6%YOY-55.6%+24.0%
TTM-31.6%5Y-329.1%+297.5%
5Y-329.1%10Y-322.3%-6.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ43.9%-92.7%+136.6%
TTM-31.6%-141.4%+109.8%
YOY-55.6%-186.1%+130.5%
3Y-104.1%-248.3%+144.2%
5Y-329.1%-338.6%+9.5%
10Y-322.3%-488.9%+166.6%
4.3.1.2. Return on Assets

Shows how efficient Arvinas is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • 8.3% Return on Assets means that Arvinas generated $0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arvinas Inc:

  • The MRQ is 8.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is -0.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ8.3%TTM-0.7%+9.0%
TTM-0.7%YOY-7.4%+6.7%
TTM-0.7%5Y-5.3%+4.6%
5Y-5.3%10Y-8.1%+2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3%-11.5%+19.8%
TTM-0.7%-11.6%+10.9%
YOY-7.4%-11.4%+4.0%
3Y-4.6%-11.8%+7.2%
5Y-5.3%-12.1%+6.8%
10Y-8.1%-13.8%+5.7%
4.3.1.3. Return on Equity

Shows how efficient Arvinas is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • 12.6% Return on Equity means Arvinas generated $0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arvinas Inc:

  • The MRQ is 12.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is -2.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ12.6%TTM-2.4%+15.0%
TTM-2.4%YOY-15.8%+13.4%
TTM-2.4%5Y-9.7%+7.3%
5Y-9.7%10Y-70.3%+60.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.6%-13.6%+26.2%
TTM-2.4%-14.9%+12.5%
YOY-15.8%-14.4%-1.4%
3Y-10.3%-17.0%+6.7%
5Y-9.7%-17.9%+8.2%
10Y-70.3%-20.1%-50.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Arvinas Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Arvinas is operating .

  • Measures how much profit Arvinas makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arvinas Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-55.5%+55.5%
TTM-55.5%YOY-74.0%+18.5%
TTM-55.5%5Y-338.4%+282.9%
5Y-338.4%10Y-328.8%-9.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM-55.5%-250.3%+194.8%
YOY-74.0%-205.1%+131.1%
3Y-116.2%-220.2%+104.0%
5Y-338.4%-342.6%+4.2%
10Y-328.8%-475.5%+146.7%
4.3.2.2. Operating Ratio

Measures how efficient Arvinas is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.62 means that the operating costs are $0.62 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Arvinas Inc:

  • The MRQ is 0.622. The company is efficient in keeping operating costs low. +1
  • The TTM is 1.464. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.622TTM1.464-0.842
TTM1.464YOY1.760-0.296
TTM1.4645Y4.456-2.992
5Y4.45610Y5.313-0.857
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6222.110-1.488
TTM1.4642.704-1.240
YOY1.7603.063-1.303
3Y2.1853.576-1.391
5Y4.4564.713-0.257
10Y5.3136.512-1.199
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Arvinas Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Arvinas is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.58 means the company has $4.58 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Arvinas Inc:

  • The MRQ is 4.578. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.252. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.578TTM4.252+0.326
TTM4.252YOY4.155+0.097
TTM4.2525Y6.671-2.419
5Y6.67110Y6.090+0.581
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5783.661+0.917
TTM4.2523.786+0.466
YOY4.1554.121+0.034
3Y4.4174.680-0.263
5Y6.6715.765+0.906
10Y6.0906.150-0.060
4.4.3.2. Quick Ratio

Measures if Arvinas is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • A Quick Ratio of 8.58 means the company can pay off $8.58 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arvinas Inc:

  • The MRQ is 8.579. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.950. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.579TTM7.950+0.630
TTM7.950YOY7.634+0.316
TTM7.9505Y11.452-3.502
5Y11.45210Y10.521+0.931
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5792.826+5.753
TTM7.9503.128+4.822
YOY7.6343.782+3.852
3Y8.2134.304+3.909
5Y11.4525.703+5.749
10Y10.5216.454+4.067
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Arvinas Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Arvinas assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arvinas to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.34 means that Arvinas assets are financed with 34.1% credit (debt) and the remaining percentage (100% - 34.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arvinas Inc:

  • The MRQ is 0.341. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.464. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.341TTM0.464-0.123
TTM0.464YOY0.533-0.069
TTM0.4645Y0.423+0.041
5Y0.42310Y0.427-0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3410.324+0.017
TTM0.4640.347+0.117
YOY0.5330.327+0.206
3Y0.5140.339+0.175
5Y0.4230.349+0.074
10Y0.4270.382+0.045
4.5.4.2. Debt to Equity Ratio

Measures if Arvinas is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arvinas to the Biotechnology industry mean.
  • A Debt to Equity ratio of 51.7% means that company has $0.52 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arvinas Inc:

  • The MRQ is 0.517. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.896. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.517TTM0.896-0.379
TTM0.896YOY1.154-0.259
TTM0.8965Y0.851+0.045
5Y0.85110Y8.742-7.891
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5170.383+0.134
TTM0.8960.436+0.460
YOY1.1540.410+0.744
3Y1.0830.446+0.637
5Y0.8510.460+0.391
10Y8.7420.509+8.233
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Arvinas generates.

  • Above 15 is considered overpriced but always compare Arvinas to the Biotechnology industry mean.
  • A PE ratio of 1.55 means the investor is paying $1.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arvinas Inc:

  • The EOD is 1.680. Based on the earnings, the company is cheap. +2
  • The MRQ is 1.545. Based on the earnings, the company is cheap. +2
  • The TTM is -7.287. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.680MRQ1.545+0.134
MRQ1.545TTM-7.287+8.832
TTM-7.287YOY-7.027-0.260
TTM-7.2875Y-15.338+8.052
5Y-15.33810Y-13.458-1.880
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.680-2.197+3.877
MRQ1.545-2.027+3.572
TTM-7.287-2.527-4.760
YOY-7.027-3.733-3.294
3Y-7.842-3.717-4.125
5Y-15.338-6.036-9.302
10Y-13.458-6.649-6.809
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arvinas Inc:

  • The EOD is -1.559. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.434. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 0.181. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-1.559MRQ-1.434-0.125
MRQ-1.434TTM0.181-1.615
TTM0.181YOY-6.497+6.678
TTM0.1815Y-13.662+13.843
5Y-13.66210Y4.315-17.978
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.559-3.007+1.448
MRQ-1.434-2.704+1.270
TTM0.181-3.627+3.808
YOY-6.497-4.334-2.163
3Y-5.059-5.070+0.011
5Y-13.662-8.532-5.130
10Y4.315-9.305+13.620
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Arvinas is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.78 means the investor is paying $0.78 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Arvinas Inc:

  • The EOD is 0.844. Based on the equity, the company is cheap. +2
  • The MRQ is 0.776. Based on the equity, the company is cheap. +2
  • The TTM is 2.393. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.844MRQ0.776+0.067
MRQ0.776TTM2.393-1.617
TTM2.393YOY4.134-1.741
TTM2.3935Y5.697-3.304
5Y5.69710Y6.346-0.649
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8441.921-1.077
MRQ0.7761.843-1.067
TTM2.3932.113+0.280
YOY4.1342.467+1.667
3Y3.6872.541+1.146
5Y5.6973.666+2.031
10Y6.3464.311+2.035
4.6.2. Total Gains per Share

2.4. Latest News of Arvinas Inc

Does Arvinas Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Arvinas Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-24
03:00
Bragar Eagel & Squire, P.C. Is Investigating Arvinas, Semler, and Abacus and Encourages Investors to Contact the FirmRead
2025-06-14
18:09
Arvinas's SWOT analysis: vepdegestrant efficacy fuels stock potential amid market challengesRead
2025-06-13
13:00
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 CongressRead
2025-06-11
14:30
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer IncidencesRead
2025-06-06
18:20
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Arvinas, Inc. - ARVNRead
2025-06-02
20:09
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Arvinas Inc.

4.8.1. Institutions holding Arvinas Inc

Institutions are holding 86.563% of the shares of Arvinas Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Group Inc11.45640.00118362200129963918.4018
2025-03-31BlackRock Inc8.45250.00096169602-396543-6.0392
2025-03-31Citadel Advisors Llc5.310.0052387584680317826.1394
2025-03-31T. Rowe Price Associates, Inc.5.24040.00333825064-277947-6.7742
2025-03-31Pfizer Inc4.73734.8467345781500
2025-03-31RTW INVESTMENTS, LLC4.56810.358333430800
2024-12-31UBS Group AG2.79270.007220384591566881332.2634
2025-03-31Opaleye Management Inc2.70583.0868197500035000021.5385
2025-03-31State Street Corp2.59780.0006189619025914015.8297
2025-03-31Alyeska Investment Group, L.P.2.4660.0503180000018000000
2025-03-31New Leaf Venture Partners, L.L.C.2.172524.7915158572100
2025-03-31Geode Capital Management, LLC2.10540.00091536796257821.7063
2024-12-31Nextech Invest AG1.92954.38140839400
2025-03-31Nextech Invest, Ltd.1.92952.2978140839414083940
2025-03-31TANG CAPITAL MANAGEMENT LLC1.90950.5413139380013938000
2025-03-31Millennium Management LLC1.79520.00491310326995483316.1839
2024-12-31NORGES BANK1.70410.0031124386816562215.3603
2025-03-31Philosophy Capital Management LLC1.36460.49689960329960320
2025-03-31Federated Hermes Inc1.34350.01499806749331831964.9681
2025-03-31UBS Asset Mgmt Americas Inc1.2370.0016902925469394108.2723
Total 67.817840.892949501414+11792038+23.8%

4.9.2. Funds holding Arvinas Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31BB Biotech AG Ord3.26071.793238000000
2025-04-30Vanguard Total Stock Mkt Idx Inv2.81540.001220549811143005.8897
2025-03-31US Small-Cap Growth II Equity Comp2.58540.08231887088-129002-6.3986
2025-03-31T. Rowe Price New Horizons2.58540.08231887088-128419-6.3715
2025-05-31iShares Russell 2000 ETF2.20290.0188160791500
2025-04-30Vanguard Small Cap Index2.13850.01071560905180871.1723
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.37860.0095100623120860.2077
2025-03-31Vanguard Explorer Inv1.19460.0308871965-332489-27.605
2025-04-30Vanguard Small Cap Growth Index Inv1.18590.024986557718670.2162
2025-03-31Vanguard Strategic Equity Inv0.89430.053665272831258091.8953
2025-03-31Fidelity Small Cap Index0.88420.018764540133080.5152
2025-03-31Federated Hermes MDT Small Cap Core IS0.83630.33676104545790091841.3388
2025-03-31Federated Hermes MDT SCC Institutional0.83630.33656104545790091841.3388
2024-12-31FIAM Small Cap Core Composite0.82390.2377601400-165200-21.5497
2025-05-31iShares Russell 2000 Growth ETF0.76160.036255588500
2025-03-31T. Rowe Price New Horizons Tr-A0.720.08175255627570.1442
2025-03-31T. Rowe Price Integrated US Sm Gr Eq0.66710.045448693600
2025-03-31T. Rowe Price Integrated US SmCapGrEq0.66710.0454486936-486936-50
2025-05-31SPDR® S&P Pharmaceuticals ETF0.59482.234243413500
2024-09-30Candriam Global Equities Oncology0.5590.4952408030247766.4646
Total 27.5925.974820139671+393733+2.0%

5.3. Insider Transactions

Insiders are holding 6.749% of the shares of Arvinas Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-03-18Noah BerkowitzSELL86588.59
2025-02-24David K LoomisSELL121416.75
2025-02-24Ian TaylorSELL902016.71
2025-02-24John G HoustonSELL3133816.72
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Income before Tax  -69,30034,300-35,000-13,600-48,6003,100-45,500128,60083,100
Net Income  -69,40034,200-35,200-14,000-49,2004,100-45,100128,00082,900
EBITDA  -81,60034,800-46,800-13,500-60,3003,700-56,600129,30072,700
Operating Income  -83,30034,800-48,500-11,800-60,3002,100-58,200129,60071,400
Net Income from Continuing Operations  -69,40034,200-35,200-14,000-49,2004,100-45,100128,00082,900



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,001,100
Total Liabilities341,000
Total Stockholder Equity660,100
 As reported
Total Liabilities 341,000
Total Stockholder Equity+ 660,100
Total Assets = 1,001,100

Assets

Total Assets1,001,100
Total Current Assets979,700
Long-term Assets21,400
Total Current Assets
Cash And Cash Equivalents 81,000
Short-term Investments 873,300
Net Receivables 8,400
Other Current Assets 17,000
Total Current Assets  (as reported)979,700
Total Current Assets  (calculated)979,700
+/-0
Long-term Assets
Property Plant Equipment 16,600
Long-term Assets Other 4,800
Long-term Assets  (as reported)21,400
Long-term Assets  (calculated)21,400
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities214,000
Long-term Liabilities127,000
Total Stockholder Equity660,100
Total Current Liabilities
Accounts payable 26,400
Other Current Liabilities 73,000
Total Current Liabilities  (as reported)214,000
Total Current Liabilities  (calculated)99,400
+/- 114,600
Long-term Liabilities
Long term Debt 500
Capital Lease Obligations Min Short Term Debt10,000
Long-term Liabilities  (as reported)127,000
Long-term Liabilities  (calculated)10,500
+/- 116,500
Total Stockholder Equity
Common Stock100
Retained Earnings -1,448,700
Accumulated Other Comprehensive Income 1,500
Other Stockholders Equity 2,107,200
Total Stockholder Equity (as reported)660,100
Total Stockholder Equity (calculated)660,100
+/-0
Other
Capital Stock100
Cash and Short Term Investments 954,300
Common Stock Shares Outstanding 72,700
Current Deferred Revenue141,000
Liabilities and Stockholders Equity 1,001,100
Net Debt -70,500
Net Invested Capital 660,600
Net Working Capital 765,700
Property Plant and Equipment Gross 42,500
Short Long Term Debt Total 10,500



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
37,937
0
0
0
66,848
116,278
105,991
98,886
199,282
186,568
172,046
209,094
301,641
282,450
262,582
271,947
717,369
681,772
644,027
1,604,865
1,581,600
1,488,300
1,407,000
1,334,800
1,268,800
1,175,800
1,083,500
1,058,300
1,304,600
1,212,600
1,279,600
1,167,100
1,091,400
1,001,100
1,001,1001,091,4001,167,1001,279,6001,212,6001,304,6001,058,3001,083,5001,175,8001,268,8001,334,8001,407,0001,488,3001,581,6001,604,865644,027681,772717,369271,947262,582282,450301,641209,094172,046186,568199,28298,886105,991116,27866,84800037,937
   > Total Current Assets 
37,282
35,557
0
0
65,529
114,443
103,693
95,518
195,678
179,736
163,261
199,663
290,881
270,195
249,582
257,980
703,088
664,657
627,734
1,576,151
1,552,500
1,457,000
1,376,400
1,304,700
1,240,200
1,148,200
1,056,700
1,033,000
1,280,200
1,190,300
1,256,700
1,149,500
1,067,300
979,700
979,7001,067,3001,149,5001,256,7001,190,3001,280,2001,033,0001,056,7001,148,2001,240,2001,304,7001,376,4001,457,0001,552,5001,576,151627,734664,657703,088257,980249,582270,195290,881199,663163,261179,736195,67895,518103,693114,44365,5290035,55737,282
       Cash And Cash Equivalents 
5,088
-35,557
0
0
30,912
60,831
3,353
6,191
3,190
28,786
11,342
12,135
9,211
36,106
21,594
88,989
588,373
346,068
48,726
255,663
108,300
62,300
93,200
132,600
81,300
130,200
90,600
113,700
317,200
93,500
160,300
85,200
100,500
81,000
81,000100,50085,200160,30093,500317,200113,70090,600130,20081,300132,60093,20062,300108,300255,66348,726346,068588,37388,98921,59436,1069,21112,13511,34228,7863,1906,1913,35360,83130,91200-35,5575,088
       Short-term Investments 
30,469
71,115
0
0
8,259
51,866
96,387
83,603
184,638
146,175
147,831
178,375
271,661
226,728
221,103
159,575
100,158
305,203
551,849
1,288,814
1,394,300
1,366,100
1,250,000
1,138,100
1,124,000
993,300
948,200
884,800
949,300
1,081,300
1,073,900
1,036,400
938,900
873,300
873,300938,9001,036,4001,073,9001,081,300949,300884,800948,200993,3001,124,0001,138,1001,250,0001,366,1001,394,3001,288,814551,849305,203100,158159,575221,103226,728271,661178,375147,831146,175184,63883,60396,38751,8668,2590071,11530,469
       Net Receivables 
1,410
0
0
0
26,040
1,435
1,962
2,179
5,032
2,470
1,402
5,202
6,281
3,878
3,564
5,956
1,000
5,175
7,416
8,636
25,700
6,700
8,100
6,800
8,000
4,700
4,800
20,600
7,200
7,100
10,000
14,800
13,700
8,400
8,40013,70014,80010,0007,1007,20020,6004,8004,7008,0006,8008,1006,70025,7008,6367,4165,1751,0005,9563,5643,8786,2815,2021,4022,4705,0322,1791,9621,43526,0400001,410
       Other Current Assets 
315
0
0
0
317
1,747
1,991
3,545
2,818
2,305
2,686
3,951
3,727
3,482
3,321
3,460
6,100
8,210
19,743
23,038
24,200
21,900
25,100
27,200
26,900
20,000
13,100
13,900
12,000
8,400
18,000
13,100
14,200
17,000
17,00014,20013,10018,0008,40012,00013,90013,10020,00026,90027,20025,10021,90024,20023,03819,7438,2106,1003,4603,3213,4823,7273,9512,6862,3052,8183,5451,9911,747317000315
   > Long-term Assets 
0
-35,557
0
0
1,320
1,835
2,298
3,368
3,604
6,832
8,785
9,430
10,761
12,255
13,000
13,968
14,281
17,116
16,293
28,714
29,100
31,300
30,600
30,100
28,600
27,600
26,800
25,300
24,400
22,300
22,900
17,600
24,100
21,400
21,40024,10017,60022,90022,30024,40025,30026,80027,60028,60030,10030,60031,30029,10028,71416,29317,11614,28113,96813,00012,25510,7619,4308,7856,8323,6043,3682,2981,8351,32000-35,5570
       Property Plant Equipment 
634
0
0
0
1,299
1,814
2,278
3,347
3,583
6,811
8,764
9,410
10,734
12,226
12,971
13,939
14,252
17,087
16,264
15,879
16,600
19,200
18,900
18,800
17,800
17,300
16,700
15,700
14,000
12,400
11,300
7,800
16,000
16,600
16,60016,0007,80011,30012,40014,00015,70016,70017,30017,80018,80018,90019,20016,60015,87916,26417,08714,25213,93912,97112,22610,7349,4108,7646,8113,5833,3472,2781,8141,299000634
       Long-term Assets Other 
0
-35,557
0
0
21
21
21
21
21
21
21
21
27
29
29
29
29
29
29
12,836
12,800
12,100
11,700
11,300
10,800
10,300
10,100
9,600
10,400
9,900
11,600
9,800
8,100
4,800
4,8008,1009,80011,6009,90010,4009,60010,10010,30010,80011,30011,70012,10012,80012,83629292929292927212121212121212100-35,5570
> Total Liabilities 
13,906
0
0
0
66,602
64,847
61,710
62,562
62,615
58,830
55,541
74,934
74,955
70,743
64,800
66,827
75,111
66,474
61,080
787,128
799,900
765,000
736,400
713,300
703,900
664,800
619,900
601,100
644,600
602,900
679,400
581,100
529,700
341,000
341,000529,700581,100679,400602,900644,600601,100619,900664,800703,900713,300736,400765,000799,900787,12861,08066,47475,11166,82764,80070,74374,95574,93455,54158,83062,61562,56261,71064,84766,60200013,906
   > Total Current Liabilities 
10,034
0
0
0
17,855
17,274
17,311
19,848
22,980
20,600
20,946
29,396
32,813
33,169
33,720
39,531
49,085
40,372
41,820
182,508
261,700
238,000
238,200
244,600
295,100
282,900
306,900
317,300
257,100
240,800
347,200
275,900
229,800
214,000
214,000229,800275,900347,200240,800257,100317,300306,900282,900295,100244,600238,200238,000261,700182,50841,82040,37249,08539,53133,72033,16932,81329,39620,94620,60022,98019,84817,31117,27417,85500010,034
       Short-term Debt 
141
454
0
0
159
164
169
195
154
648
719
597
674
900
921
940
1,000
1,217
1,221
1,123
2,200
3,400
3,400
3,600
1,800
3,900
3,900
4,000
1,900
1,500
1,200
1,600
1,800
0
01,8001,6001,2001,5001,9004,0003,9003,9001,8003,6003,4003,4002,2001,1231,2211,2171,00094092190067459771964815419516916415900454141
       Short Long Term Debt 
141
454
0
0
159
164
169
195
154
113
71
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
200
0
0
0
0
0
0
000000200100100000000000000007111315419516916415900454141
       Accounts payable 
1,566
0
0
0
597
1,967
1,657
1,301
2,758
1,564
1,411
2,278
4,557
3,021
2,430
5,088
7,100
9,003
4,975
4,672
31,300
8,600
12,300
7,900
5,700
12,300
6,700
34,300
17,800
17,800
23,200
17,700
13,200
26,400
26,40013,20017,70023,20017,80017,80034,3006,70012,3005,7007,90012,3008,60031,3004,6724,9759,0037,1005,0882,4303,0214,5572,2781,4111,5642,7581,3011,6571,9675970001,566
       Other Current Liabilities 
8,327
0
0
0
3,546
15,143
1,985
4,851
4,001
2,948
3,999
6,227
7,603
6,784
7,404
12,144
40,985
8,001
13,473
13,769
22,000
24,000
28,100
38,000
58,700
41,700
65,200
53,700
73,700
55,200
319,400
72,400
57,200
73,000
73,00057,20072,400319,40055,20073,70053,70065,20041,70058,70038,00028,10024,00022,00013,76913,4738,00140,98512,1447,4046,7847,6036,2273,9992,9484,0014,8511,98515,1433,5460008,327
   > Long-term Liabilities 
0
0
0
0
48,748
47,573
44,399
42,714
39,635
38,230
34,595
45,538
42,142
37,574
31,080
27,297
26,026
26,103
19,259
604,620
538,200
527,000
498,200
468,700
408,800
381,900
313,000
283,800
387,500
362,100
332,200
305,200
299,900
127,000
127,000299,900305,200332,200362,100387,500283,800313,000381,900408,800468,700498,200527,000538,200604,62019,25926,10326,02627,29731,08037,57442,14245,53834,59538,23039,63542,71444,39947,57348,7480000
       Long term Debt Total 
0
0
0
0
0
109
65
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
900
900
0
0
0
0
0
0
0
00000009009001,0001,0001,0001,0001,0001,0001,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,0002,0006510900000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
2,671
2,541
2,365
2,388
2,743
2,512
2,291
2,040
4,919
4,618
4,314
4,000
5,800
5,300
4,900
4,500
4,000
3,500
3,000
2,400
1,900
1,400
900
9,100
10,000
10,0009,1009001,4001,9002,4003,0003,5004,0004,5004,9005,3005,8004,0004,3144,6184,9192,0402,2912,5122,7432,3882,3652,5412,671000000000
       Warrants
0
0
0
0
0
0
0
315,167
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000315,1670000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
40,714
37,635
2,137
32,595
43,538
40,142
35,574
29,080
25,297
24,026
24,103
18,259
603,620
537,200
526,000
497,200
467,700
407,800
381,000
312,100
0
0
0
100
0
0
0
000100000312,100381,000407,800467,700497,200526,000537,200603,62018,25924,10324,02625,29729,08035,57440,14243,53832,5952,13737,63540,7140000000
> Total Stockholder Equity
24,031
24,088
0
0
246
51,431
44,281
36,324
136,667
127,738
116,505
134,160
226,686
211,707
197,781
205,120
642,258
615,298
582,947
817,737
781,700
723,300
670,600
621,500
564,900
511,000
463,600
457,200
660,000
609,700
600,200
586,000
561,700
660,100
660,100561,700586,000600,200609,700660,000457,200463,600511,000564,900621,500670,600723,300781,700817,737582,947615,298642,258205,120197,781211,707226,686134,160116,505127,738136,66736,32444,28151,4312460024,08824,031
   Common Stock
948
0
0
0
1,193
6
22
4
31
31
32
33
38
39
39
40
48
49
49
53
0
0
100
100
100
100
100
100
100
100
100
100
100
100
1001001001001001001001001001001001000053494948403939383332313142261,193000948
   Retained Earnings Total Equity0000000-1,113,900-1,047,300-965,400-882,500-816,300-746,300-682,900-629,894-583,142-532,853-491,889-450,342-419,523-394,296-372,557-351,509-333,834-316,669-302,265-286,1770000000
   Accumulated Other Comprehensive Income 
0
-32,879
0
0
-10
1,265
-97
-47
-218
80
300
197
108
-603
1,664
1,080
561
-243
-487
-677
-4,600
-18,700
-22,000
-24,800
-19,200
-12,600
-12,200
-9,200
-3,100
-4,400
-3,800
4,100
1,000
1,500
1,5001,0004,100-3,800-4,400-3,100-9,200-12,200-12,600-19,200-24,800-22,000-18,700-4,600-677-487-2435611,0801,664-60310819730080-218-47-971,265-1000-32,8790
   Capital Surplus 
0
0
0
0
0
0
0
7,378
439,118
444,295
450,007
485,439
599,097
606,567
615,601
654,342
1,133,537
1,148,345
1,166,526
1,448,255
1,469,200
1,488,300
1,508,800
1,528,700
1,549,400
1,570,800
1,589,600
0
0
0
0
0
0
0
00000001,589,6001,570,8001,549,4001,528,7001,508,8001,488,3001,469,2001,448,2551,166,5261,148,3451,133,537654,342615,601606,567599,097485,439450,007444,295439,1187,3780000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
913
-32,879
0
0
1,177
1,265
2,053
7,378
439,118
444,295
450,007
485,439
599,097
606,567
615,601
654,342
1,133,537
1,148,345
1,166,526
1,448,255
1,469,200
1,488,300
1,508,800
1,528,700
1,549,400
1,570,800
1,589,600
1,644,200
1,995,700
2,016,100
2,041,200
2,068,300
2,092,200
2,107,200
2,107,2002,092,2002,068,3002,041,2002,016,1001,995,7001,644,2001,589,6001,570,8001,549,4001,528,7001,508,8001,488,3001,469,2001,448,2551,166,5261,148,3451,133,537654,342615,601606,567599,097485,439450,007444,295439,1187,3782,0531,2651,17700-32,879913



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue263,400
Cost of Revenue-6,600
Gross Profit256,800256,800
 
Operating Income (+$)
Gross Profit256,800
Operating Expense-513,600
Operating Income-250,200-256,800
 
Operating Expense (+$)
Research Development348,200
Selling General Administrative165,400
Selling And Marketing Expenses0
Operating Expense513,600513,600
 
Net Interest Income (+$)
Interest Income54,800
Interest Expense-0
Other Finance Cost-0
Net Interest Income54,800
 
Pretax Income (+$)
Operating Income-250,200
Net Interest Income54,800
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-198,300-302,100
EBIT - interestExpense = -256,800
-198,300
-198,900
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-256,800-198,300
Earnings Before Interest and Taxes (EBITDA)-250,200
 
After tax Income (+$)
Income Before Tax-198,300
Tax Provision-600
Net Income From Continuing Ops-198,900-198,900
Net Income-198,900
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses513,600
Total Other Income/Expenses Net51,900-54,800
 

Technical Analysis of Arvinas
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arvinas. The general trend of Arvinas is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arvinas's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Arvinas Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arvinas Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.24 < 9.68 < 13.57.

The bearish price targets are: 7.09 > 6.7 > 5.935.

Know someone who trades $ARVN? Share this with them.👇

Arvinas Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arvinas Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arvinas Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arvinas Inc. The current macd is 0.0768437.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arvinas price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Arvinas. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Arvinas price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Arvinas Inc Daily Moving Average Convergence/Divergence (MACD) ChartArvinas Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arvinas Inc. The current adx is 11.15.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Arvinas shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Arvinas Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arvinas Inc. The current sar is 8.10871874.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Arvinas Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arvinas Inc. The current rsi is 53.52. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Arvinas Inc Daily Relative Strength Index (RSI) ChartArvinas Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arvinas Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arvinas price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Arvinas Inc Daily Stochastic Oscillator ChartArvinas Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arvinas Inc. The current cci is 29.17.

Arvinas Inc Daily Commodity Channel Index (CCI) ChartArvinas Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arvinas Inc. The current cmo is 10.38.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Arvinas Inc Daily Chande Momentum Oscillator (CMO) ChartArvinas Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arvinas Inc. The current willr is -44.32989691.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Arvinas is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Arvinas Inc Daily Williams %R ChartArvinas Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arvinas Inc.

Arvinas Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arvinas Inc. The current atr is 0.4429238.

Arvinas Inc Daily Average True Range (ATR) ChartArvinas Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arvinas Inc. The current obv is -22,039,688.

Arvinas Inc Daily On-Balance Volume (OBV) ChartArvinas Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arvinas Inc. The current mfi is 35.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Arvinas Inc Daily Money Flow Index (MFI) ChartArvinas Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arvinas Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Arvinas Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arvinas Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.518
Ma 20Greater thanMa 507.486
Ma 50Greater thanMa 1007.450
Ma 100Greater thanMa 2009.819
OpenGreater thanClose7.400
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Arvinas with someone you think should read this too:
  • Are you bullish or bearish on Arvinas? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arvinas? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arvinas Inc

I send you an email if I find something interesting about Arvinas Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Arvinas Inc.

Receive notifications about Arvinas Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.